MedPath

EPTIFIBATIDE INJECTION

EPTIFIBATIDE INJECTION

Approved
DIN Number

02540819

Drug Class

Human

Market Date

May 16, 2024

Company
HC

Juno Pharmaceuticals Corp.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02540819
AIG Number0137621001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AC16 EPTIFIBATIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:12.18
Health Canada Classification

ACTIVE INGREDIENTS (1)

EPTIFIBATIDEActive
Strength: 0.75 MG / ML
Monograph: EPTIFIBATIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.